ReviewWorld journal of urology2025
Long-term results of retrograde endopyelotomy: a narrative review.
Review in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Challenging recurrent ureteropelvic junction obstructions: endoscopic procedures versus redo-pyeloplasty-a systematic review and meta-analysis.World journal of urology · 2026Pooled it
- Multimodal treatment for failed pyeloplasty: Description of a new technique.Urology case reports · 2026Article
- Simultaneous Mini-ECIRS and low-energy TFL endopyelotomy for recurrent UPJO with pelvic renal calculus: A case report.Urology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRetrograde endopyelotomy has emerged as a minimally invasive alternative for treating ureteropelvic junction obstruction (UPJO), characterized by impaired urinary transport due to intrinsic or extrinsic factors. This narrative review evaluates the long-term outcomes of retrograde endopyelotomy, focusing on effectiveness, safety, complications, and reoperation requirements.
methodsA systematic search of PubMed, Google Scholar, and Scopus from 1990 to March 2024 identified 29 studies comprising 1238 adult patients.
resultsFindings indicate that retrograde endopyelotomy, predominantly performed using Holmium:YAG lasers, achieved a mean success rate of 76.9%, with variability based on the type of obstruction and intervention methods. Success was inconsistently defined across studies, ranging from symptom resolution to imaging-based criteria. Complication rates averaged 12.5%, with urinary tract infections being the most common. Hospital stays were typically brief, with most patients discharged within 1-3 days.
conclusionRetrograde endopyelotomy, has the advantage of shorter recovery times and reduced invasiveness compared to open or laparoscopic approaches. Future studies should also explore advancements in laser technology, such as Thulium Fiber Laser, to optimize outcomes.
Indexed as
Identifiers
40316769What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.